Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
NCT05866510
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Utidelone and anlotinib
Sponsor
Peking University
Collaborators
[object Object]
[object Object]